{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:49:15Z","timestamp":1791204555929,"version":"4.2.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Singapore Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Medical Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.antiviral.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T23:04:06Z","timestamp":1440198246000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Animal models for studying dengue pathogenesis and therapy"],"prefix":"10.1016","volume":"123","author":[{"given":"Kitti Wing Ki","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranmali","family":"Kavishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash G.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.08.013_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/viro.1999.9887","article-title":"Development of a novel mouse model for dengue virus infection","volume":"263","author":"An","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0010","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.08.013_b0015","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1128\/JVI.79.21.13797-13799.2005","article-title":"Dengue fever in humanized NOD\/SCID mice","volume":"79","author":"Bente","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.08.013_b0025","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0035-9203(87)90041-1","article-title":"Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever\/dengue shock syndrome (DHF\/DSS)","volume":"81","author":"Bravo","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0035","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.013_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","article-title":"Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo","volume":"89","author":"Chang","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0045","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1086\/648407","article-title":"Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants","volume":"200","author":"Chau","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/590117","article-title":"Dengue in Vietnamese infants\u2013results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity","volume":"198","author":"Chau","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0055","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/JVI.02575-06","article-title":"Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jmv.20108","article-title":"Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus","volume":"73","author":"Chen","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nature07013","article-title":"CLEC5A is critical for dengue-virus-induced lethal disease","volume":"453","author":"Chen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.08.013_b0070","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1371\/journal.pone.0001192","article-title":"High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection","volume":"2","author":"Dong","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.08.013_b0075","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.013_b0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/jis749","article-title":"The dengue human challenge model: has the time come to accept this challenge?","volume":"207","author":"Durbin","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0085","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0090","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/JVI.03085-13","article-title":"Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing","volume":"88","author":"Frias-Staheli","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2014.03.011","article-title":"Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys","volume":"456\u2013457","author":"Gil","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0100","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.013_b0105","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jmb.2013.11.023","article-title":"Innate immunity to dengue virus infection and subversion of antiviral responses","volume":"426","author":"Green","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0470058005.ch2","article-title":"Dengue\/dengue haemorrhagic fever: history and current status","volume":"277","author":"Gubler","year":"2006","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.antiviral.2015.08.013_b0115","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0120","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.vaccine.2011.03.038","article-title":"A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness","volume":"29","author":"Gunther","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.08.013_b0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"issue":"9966","key":"10.1016\/j.antiviral.2015.08.013_b0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.013_b0140","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","article-title":"In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody","volume":"140","author":"Halstead","year":"1979","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0145","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/oxfordjournals.aje.a113235","article-title":"The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease","volume":"114","author":"Halstead","year":"1981","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.013_b0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0160","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.013_b0165","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3201\/eid0812.020170","article-title":"Dengue hemorrhagic fever in infants: research opportunities ignored","volume":"8","author":"Halstead","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0180","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1099\/0022-1317-81-9-2177","article-title":"Manifestation of thrombocytopenia in dengue-2-virus-infected mice","volume":"81","author":"Huang","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0185","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0190","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","article-title":"Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers","volume":"19","author":"Kanesa-thasan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.08.013_b0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2007.06.005","article-title":"Dengue virus infection and immune response in humanized RAG2(\u2212\/\u2212)gamma(c)(\u2212\/\u2212) (RAG-hu) mice","volume":"369","author":"Kuruvilla","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2008.08.008","article-title":"Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model","volume":"380","author":"Kyle","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0210","first-page":"1","article-title":"Characterization of the activity of 2\u2032-C-methylcytidine against dengue virus replication","volume":"116C","author":"Lee","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1423-0127-20-65","article-title":"Dengue virus infection induces autophagy: an in vivo study","volume":"20","author":"Lee","year":"2013","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2015.08.013_b0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000081744","article-title":"Suckling mice were used to detect infectious dengue-2 viruses by intracerebral injection of the full-length RNA transcript","volume":"48","author":"Lee","year":"2005","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0225","doi-asserted-by":"crossref","first-page":"e1000171","DOI":"10.1371\/journal.pmed.1000171","article-title":"A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model","volume":"6","author":"Libraty","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2015.08.013_b0230","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1128\/JVI.72.12.9729-9737.1998","article-title":"Study of Dengue virus infection in SCID mice engrafted with human K562 cells","volume":"72","author":"Lin","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0235","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.vaccine.2013.12.040","article-title":"Evaluation of dengue virus strains for human challenge studies","volume":"32","author":"Mammen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.08.013_b0240","doi-asserted-by":"crossref","first-page":"e0125476","DOI":"10.1371\/journal.pone.0125476","article-title":"A dengue virus type 4 model of disseminated lethal infection in AG129 mice","volume":"10","author":"Milligan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.08.013_b0245","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1128\/JVI.00581-09","article-title":"Humanized mice show clinical signs of dengue fever according to infecting virus genotype","volume":"83","author":"Mota","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0250","doi-asserted-by":"crossref","first-page":"e20762","DOI":"10.1371\/journal.pone.0020762","article-title":"Dengue virus tropism in humanized mice recapitulates human dengue fever","volume":"6","author":"Mota","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.08.013_b0255","doi-asserted-by":"crossref","first-page":"e1004031","DOI":"10.1371\/journal.ppat.1004031","article-title":"First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies","volume":"10","author":"Ng","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.08.013_b0260","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1099\/vir.0.031229-0","article-title":"Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity","volume":"92","author":"Omatsu","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0684.2012.00552.x","article-title":"Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus","volume":"41","author":"Omatsu","year":"2012","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0270","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","article-title":"Dengue virus-induced hemorrhage in a nonhuman primate model","volume":"115","author":"Onlamoon","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2015.08.013_b0275","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0280","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4269\/ajtmh.2011.10-0592","article-title":"Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques","volume":"84","author":"Osorio","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0285","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bcp.12146","article-title":"Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing","volume":"76","author":"Oxford","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0290","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood-2003-02-0384","article-title":"Human dendritic cell subsets in NOD\/SCID mice engrafted with CD34+ hematopoietic progenitors","volume":"102","author":"Palucka","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2015.08.013_b0295","doi-asserted-by":"crossref","first-page":"e1001297","DOI":"10.1371\/journal.ppat.1001297","article-title":"STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor","volume":"7","author":"Perry","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.08.013_b0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2013.01.004","article-title":"An iminosugar with potent inhibition of dengue virus infection in vivo","volume":"98","author":"Perry","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0305","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha\/beta receptor-deficient mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0310","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1128\/JVI.00611-08","article-title":"A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads","volume":"82","author":"Prestwood","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0320","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.013_b0325","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.101.2634.640","article-title":"Production of immunity to dengue with virus modified by propagation in mice","volume":"101","author":"Sabin","year":"1945","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.013_b0330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"Sarathy","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0335","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4269\/ajtmh.1978.27.590","article-title":"Experimental infection of chimpanzees with dengue viruses","volume":"27","author":"Scherer","year":"1978","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0340","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2003.09.048","article-title":"Early activation of natural killer and B cells in response to primary dengue virus infection in A\/J mice","volume":"319","author":"Shresta","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.013_b0350","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","article-title":"Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0355","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0360","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.4049\/jimmunol.175.6.3946","article-title":"Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice","volume":"175","author":"Shresta","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0365","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1128\/JVI.79.9.5665-5675.2005","article-title":"Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections","volume":"79","author":"Simmons","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0370","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/512162","article-title":"Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever","volume":"195","author":"Simmons","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.antiviral.2015.08.013_b9000","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2015.08.013_b0375","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/jiu063","article-title":"Controlled human malaria infection","volume":"209","author":"Spring","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0380","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1128\/JVI.01156-13","article-title":"Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice","volume":"87","author":"Sridharan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0385","doi-asserted-by":"crossref","unstructured":"St John, A.L., Rathore, A.P., Raghavan, B., Ng, M.-L., Abraham, S.N., 2013. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage.","DOI":"10.7554\/eLife.00481"},{"key":"10.1016\/j.antiviral.2015.08.013_b0390","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcu.20476","article-title":"Sonographic findings of healthy volunteers infected with dengue virus","volume":"36","author":"Statler","year":"2008","journal-title":"J. Clin. Ultrasound: JCU"},{"key":"10.1016\/j.antiviral.2015.08.013_b0395","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/infdis\/jis744","article-title":"Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines","volume":"207","author":"Sun","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.08.013_b0405","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1371\/journal.pntd.0000672","article-title":"A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice","volume":"4","author":"Tan","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0410","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4161\/hv.24188","article-title":"Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development","volume":"9","author":"Thomas","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2015.08.013_b0415","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/nyas.12413","article-title":"Developing a dengue vaccine: progress and future challenges","volume":"1323","author":"Thomas","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2015.08.013_b0420","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.013_b0425","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.08.013_b0430","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jinf.2014.01.006","article-title":"Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies","volume":"68","author":"Waddington","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2015.08.013_b0435","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly-neutralizing levels of cross-reactive antibodies cause acute lethal small intestinal pathology without high level of viremia in mice","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0440","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"Watanabe","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.013_b0445","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1128\/JVI.07081-11","article-title":"The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model","volume":"86","author":"Watanabe","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0450","first-page":"149","article-title":"Functional and phenotypic characterization of the humanized BLT mouse model","volume":"324","author":"Wege","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0455","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.013_b0460","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/infdis\/jiu062","article-title":"Dengue human infection models supporting drug development","volume":"209","author":"Whitehorn","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.013_b0465","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2009.03.083","article-title":"A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells","volume":"27","author":"Yamanaka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.08.013_b0470","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0475","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0480","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.013_b0485","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2015.08.013_b0490","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue reinfection in mice","author":"Zellweger","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0495","doi-asserted-by":"crossref","first-page":"e86573","DOI":"10.1371\/journal.pone.0086573","article-title":"Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.08.013_b0500","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.013_b0505","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1128\/JVI.03827-13","article-title":"Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines","volume":"88","author":"Zust","year":"2014","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:22:21Z","timestamp":1599481341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":102,"alternative-id":["S0166354215001990"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for studying dengue pathogenesis and therapy","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}